MAM
ROIV icon

Melqart Asset Management’s Roivant Sciences ROIV Stock Holding History

Melqart Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-502,584
Closed -$5.07M – 43
2025
Q1 		$5.07M Sell
502,584
-239,486
-32% -$2.59M 0.66% 36
2024
Q4 		$8.78M Hold
742,070
– – 1.06% 28
2024
Q3 		$8.56M Sell
742,070
-523,539
-41% -$5.96M 0.77% 36
2024
Q2 		$13.4M Buy
+1,265,609
New +$13.9M 1.11% 28

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Melqart Asset Management's ROIV Position: Q2 2025 in Review

Melqart Asset Management sold out of Roivant Sciences (ROIV) in Q2 2025, closing a stake of 502,584 shares — an estimated $5.07M sold.

Melqart Asset Management first reported a position in ROIV in Q2 2024 and held it in 4 quarters. The position peaked at $13.4M in Q2 2024. 337 funds tracked by Wall St. Rank hold ROIV as of Q2 2025.

  • Melqart Asset Management reported no remaining Roivant Sciences position as of Q2 2025 after selling out during the quarter.
  • Melqart Asset Management sold 502,584 Roivant Sciences shares in Q2 2025, an estimated $5.07M.
  • Melqart Asset Management first reported a position in Roivant Sciences in Q2 2024 and held it in 4 quarters.
  • Melqart Asset Management's Roivant Sciences position peaked at $13.4M in Q2 2024.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2025.

Based on Melqart Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.